Francesco Malandrini

MALANDRINI, F., M. MEREGAGLIA, M. DI MAIO, C. PINTO, F. DE LORENZO, O. CIANI, "The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project", European Journal of Cancer, 2024, vol. 207, pp. 114161

VALSECCHI, A. A., F. GIOVANARDI, F. MALANDRINI, M. MEREGAGLIA, A. SERVETTO, C. BENNATI, C. PINTO, M. DI MAIO, O. CIANI, "Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project", The Breast, 2024, vol. 78, pp. 103817

ARMENI, P., L. CAVALLARO, F. COSTA, F. MALANDRINI, M. OTTO, "Politiche del farmaco: approfondimento sul Value Framework per i farmaci" in Rapporto OASI 2024., CERGAS (Ed.), Egea, chap. 8, pp. 333-362, 2024

MEREGAGLIA, M., F. MALANDRINI, A. P. FINCH, O. CIANI, C. JOMMI, "EQ-5D-5L Population Norms for Italy", Applied Health Economics and Health Policy, 2023, vol. 21, no. 2, pp. 289-303

MALANDRINI, F., C. BORRONI, M. MEREGAGLIA, M. SARRA, O. CIANI, "Il ruolo degli esiti riferiti dal paziente nelle decisioni di rimborso e innovatività dei farmaci in Italia - The role of patient-reported outcomes in reimbursement decisions and drug innovation in Italy", Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2023, vol. 10, no. 1, pp. 12-17

TARANTOLA, A., M. OTTO, P. ARMENI, F. COSTA, F. MALANDRINI, C. JOMMI, "Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case", Journal of Pharmaceutical Policy and Practice, 2023, vol. 16, no. 1, pp. 67

MEREGAGLIA, M., F. MALANDRINI, S. ANGELINI, O. CIANI, "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022", Applied Health Economics and Health Policy, 2023, no. 21, pp. 925-935

ARMENI, P., F. COSTA, C. JOMMI, F. MALANDRINI, M. OTTO, A. TARANTOLA, "L’evoluzione del finanziamento dei farmaci in Italia" in Rapporto OASI 2023., CERGAS (Ed.), Egea, chap. 8, pp. 317-354, 2023

ARMENI, P., G. CALLEA, F. COSTA, F. MALANDRINI, M. OTTO, G. SEGANTIN, P. SIRENA, R. TARRICONE, "Il payback come misura di contenimento della spesa per farmaci e dispositivi medici" in Rapporto OASI 2023., CERGAS (Ed.), Egea, chap. 17, pp. 651-698, 2023

ARMENI, P., F. COSTA, F. MALANDRINI, A. TARANTOLA - "Report OSFAR-Osservatorio Farmaci n.42" - 2022, CERGAS - SDA Bocconi, Milano, Italy